Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis

NCT02341417 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism, Chronic Kidney Disease

Interventions

DRUG: Cinacalcet

Sponsor

Amgen